{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:09:22Z","timestamp":1795039762239,"version":"4.10.2"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10533-z","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:27:26Z","timestamp":1745818046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antimicrobial peptides: evolving soldiers in the battle against drug-resistant superbugs"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5620-633X","authenticated-orcid":false,"given":"Piyush","family":"Baindara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9572-8093","authenticated-orcid":false,"given":"Sumeeta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-2305","authenticated-orcid":false,"given":"Roy","family":"Dinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-7138","authenticated-orcid":false,"given":"Santi M.","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"10533_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/healthcare11131946","volume":"11","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT et al (2023) Antimicrobial resistance: A growing serious threat for global public health. Healthc 11:1\u201320. https:\/\/doi.org\/10.3390\/healthcare11131946","journal-title":"Healthc"},{"key":"10533_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-1-4831-9711-1.50022-3","volume":"11","author":"C Lee Ventola","year":"1963","unstructured":"Lee Ventola C M (1963) The antibiotic resistance crisis part 1: causes and threats. Compr Biochem 11:181\u2013224. https:\/\/doi.org\/10.1016\/B978-1-4831-9711-1.50022-3","journal-title":"Compr Biochem"},{"key":"10533_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2021.795433","volume":"9","author":"T Matthyssen","year":"2022","unstructured":"Matthyssen T, Li W, Holden JA et al (2022) The potential of modified and multimeric antimicrobial peptide materials as Superbug killers. Front Chem 9:1\u201323. https:\/\/doi.org\/10.3389\/fchem.2021.795433","journal-title":"Front Chem"},{"key":"10533_CR4","doi-asserted-by":"publisher","unstructured":"Terreni M, Taccani M, Pregnolato M (2021) New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules 26. https:\/\/doi.org\/10.3390\/molecules26092671","DOI":"10.3390\/molecules26092671"},{"key":"10533_CR5","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang G, Li X, Wang Z (2016) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44:D1087\u2013D1093. https:\/\/doi.org\/10.1093\/nar\/gkv1278","journal-title":"Nucleic Acids Res"},{"key":"10533_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","volume":"40","author":"M Mahlapuu","year":"2020","unstructured":"Mahlapuu M, Bj\u00f6rn C, Ekblom J (2020) Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 40:978\u2013992","journal-title":"Crit Rev Biotechnol"},{"key":"10533_CR7","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J, Sun LC, Huang S et al (2019) The antimicrobial peptides and their potential clinical applications. Am J Transl Res 11:3919\u20133931","journal-title":"Am J Transl Res"},{"key":"10533_CR8","first-page":"72","volume":"37","author":"C Walsh","year":"2017","unstructured":"Walsh C (2017) Where will new antibiotics come from? Pharm Eng 37:72","journal-title":"Pharm Eng"},{"key":"10533_CR9","doi-asserted-by":"publisher","unstructured":"Nagarajan D, Roy N, Kulkarni O et al (2019) W76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii. Sci Adv 5. https:\/\/doi.org\/10.1126\/sciadv.aax1946","DOI":"10.1126\/sciadv.aax1946"},{"key":"10533_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2021.678330","volume":"12","author":"SP Chen","year":"2021","unstructured":"Chen SP, Chen EHL, Yang SY et al (2021) A systematic study of the stability, safety, and efficacy of the de Novo designed antimicrobial peptide PepD2 and its modified derivatives against Acinetobacter baumannii. Front Microbiol 12:1\u201312. https:\/\/doi.org\/10.3389\/fmicb.2021.678330","journal-title":"Front Microbiol"},{"key":"10533_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.02086","volume":"10","author":"NM Mohan","year":"2019","unstructured":"Mohan NM, Zorgani A, Jalowicki G et al (2019) Unlocking NuriPep 1653 from common pea protein: A potent antimicrobial peptide to tackle a Pan-Drug resistant Acinetobacter baumannii. Front Microbiol 10:1\u201316. https:\/\/doi.org\/10.3389\/fmicb.2019.02086","journal-title":"Front Microbiol"},{"key":"10533_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C et al (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13:1057\u20131098","journal-title":"Lancet Infect Dis"},{"key":"10533_CR13","doi-asserted-by":"crossref","unstructured":"Dadgostar P, Ng WJ, Hing CL, Loo CB, Hoh EK, Loke IL, Ee KY (2019) (2023). Ginger-enriched honey attenuates antibiotic resistant pseudomonas aeruginosa quorum sensing virulence factors and biofilm formation. Antibiotics 12(7):1123. Infect Drug Resist 12:3903\u20133910","DOI":"10.3390\/antibiotics12071123"},{"key":"10533_CR14","doi-asserted-by":"publisher","unstructured":"Zaman S, Bin, Hussain MA, Nye R et al (2017) A review on antibiotic resistance: alarm bells are ringing. Cureus 9. https:\/\/doi.org\/10.7759\/cureus.1403","DOI":"10.7759\/cureus.1403"},{"key":"10533_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1590\/S1807-59322010000900002","volume":"65","author":"MRG Franco","year":"2010","unstructured":"Franco MRG, Caiaffa-Filho HH, Burattini MN, Rossi F (2010) Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics 65:825\u2013829. https:\/\/doi.org\/10.1590\/S1807-59322010000900002","journal-title":"Clinics"},{"key":"10533_CR16","doi-asserted-by":"publisher","unstructured":"Fyfe C, Grossman TH, Kerstein K, Sutcliffe J (2016) Resistance to macrolide antibiotics in public health pathogens. Cold Spring Harb Perspect Med 6. https:\/\/doi.org\/10.1101\/cshperspect.a025395","DOI":"10.1101\/cshperspect.a025395"},{"key":"10533_CR17","doi-asserted-by":"publisher","unstructured":"Cheng SS, Yang GJ, Wang W et al (2020) The design and development of covalent protein-protein interaction inhibitors for cancer treatment. J Hematol Oncol 13, 26. https:\/\/doi.org\/10.1186\/s13045-020-00850-0","DOI":"10.1186\/s13045-020-00850-0"},{"key":"10533_CR18","doi-asserted-by":"publisher","unstructured":"Partridge SR, Kwong SM, Firth N, Jensen SO (2018) Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev 31, 4. https:\/\/doi.org\/10.1128\/cmr.00088-17","DOI":"10.1128\/cmr.00088-17"},{"key":"10533_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajps.2019.03.002","volume":"15","author":"LK Ruddaraju","year":"2020","unstructured":"Ruddaraju LK, Pammi SVN, Guntuku G, sankar et al (2020) A review on anti-bacterials to combat resistance: from ancient era of plants and metals to present and future perspectives of green nano technological combinations. Asian J Pharm Sci 15:42\u201359. https:\/\/doi.org\/10.1016\/j.ajps.2019.03.002","journal-title":"Asian J Pharm Sci"},{"key":"10533_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02656-17","volume":"62","author":"M Han","year":"2018","unstructured":"Han M, Zhu Y, Creek DJ et al (2018) Alterations of metabolic and lipid profiles in polymyxin-. Antimicrob Agents Chemother 62:1\u201314","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR21","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.1201313109","volume":"109","author":"JV Hankins","year":"2012","unstructured":"Hankins JV, Madsen JA, Giles DK et al (2012) Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria. Proc Natl Acad Sci U S A 109:8722\u20138727. https:\/\/doi.org\/10.1073\/pnas.1201313109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10533_CR22","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1039\/d0cs00729c","volume":"50","author":"BH Gan","year":"2021","unstructured":"Gan BH, Gaynord J, Rowe SM et al (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50:7820\u20137880. https:\/\/doi.org\/10.1039\/d0cs00729c","journal-title":"Chem Soc Rev"},{"key":"10533_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrmicro1839","volume":"6","author":"YM Zhang","year":"2008","unstructured":"Zhang YM, Rock CO (2008) Membrane lipid homeostasis in bacteria. Nat Rev Microbiol 6:222\u2013233. https:\/\/doi.org\/10.1038\/nrmicro1839","journal-title":"Nat Rev Microbiol"},{"key":"10533_CR24","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","volume":"1788","author":"K Matsuzaki","year":"2009","unstructured":"Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta - Biomembr 1788:1687\u20131692. https:\/\/doi.org\/10.1016\/j.bbamem.2008.09.013","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10533_CR25","first-page":"1154","volume":"21","author":"AJ Verkleij","year":"1973","unstructured":"Verkleij AJ, Zwaal RFA, Roelofsen B, Comfurius P DK and LLMVD (1973) The asymmetric distribution of phospholipids in the human red cell membrane. Bba 21:1154\u20131157","journal-title":"Bba"},{"key":"10533_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/B978-012526451-8\/50011-4","volume":"55","author":"MRY Yount","year":"2003","unstructured":"Yount MRY and NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:453\u2013499. https:\/\/doi.org\/10.1016\/B978-012526451-8\/50011-4","journal-title":"Pharmacol Rev"},{"key":"10533_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/bip.20911","volume":"90","author":"Z Jiang","year":"2008","unstructured":"Jiang Z, Vasil AI, Hale JD et al (2008) Effects of net charge and the number of positively charged residues on the biological activity of amphipathic \u03b1-helical cationic antimicrobial peptides. Biopolym - Pept Sci Sect.\u00a090:369\u2013383. https:\/\/doi.org\/10.1002\/bip.20911","journal-title":"Biopolym - Pept Sci Sect"},{"key":"10533_CR28","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1074\/jbc.M111.332270","volume":"287","author":"M Paulmann","year":"2012","unstructured":"Paulmann M, Arnold T, Linke D et al (2012) Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem 287:8434\u20138443. https:\/\/doi.org\/10.1074\/jbc.M111.332270","journal-title":"J Biol Chem"},{"key":"10533_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1515\/bmc-2015-0014","volume":"6","author":"M Cytry\u0144ska","year":"2015","unstructured":"Cytry\u0144ska M, Zdybicka-Barabas A (2015) Defense peptides: recent developments. Biomol Concepts 6:237\u2013251. https:\/\/doi.org\/10.1515\/bmc-2015-0014","journal-title":"Biomol Concepts"},{"key":"10533_CR30","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1128\/JB.00206-07","volume":"189","author":"A Bellomio","year":"2007","unstructured":"Bellomio A, Vincent PA, De Arcuri BF et al (2007) Microcin J25 has dual and independent mechanisms of action in Escherichia coli: RNA polymerase Inhibition and increased superoxide production. J Bacteriol 189:4180\u20134186. https:\/\/doi.org\/10.1128\/JB.00206-07","journal-title":"J Bacteriol"},{"key":"10533_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbamem.2015.11.004","volume":"1858","author":"N Malanovic","year":"2016","unstructured":"Malanovic N, Lohner K (2016) Gram-positive bacterial cell envelopes: the impact on the activity of antimicrobial peptides. Biochim Biophys Acta - Biomembr 1858:936\u2013946. https:\/\/doi.org\/10.1016\/j.bbamem.2015.11.004","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10533_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/AAC.38.2.374","volume":"38","author":"I Ofek","year":"1994","unstructured":"Ofek I, Cohen S, Rahmani R et al (1994) Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother 38:374\u2013377. https:\/\/doi.org\/10.1128\/AAC.38.2.374","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1574-6976.2007.00094.x","volume":"32","author":"W Vollmer","year":"2008","unstructured":"Vollmer W, Blanot D, De Pedro MA (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32:149\u2013167. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00094.x","journal-title":"FEMS Microbiol Rev"},{"key":"10533_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02340-16","volume":"61","author":"CF Le","year":"2017","unstructured":"Le CF (2017) Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 61:1\u201316","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR35","doi-asserted-by":"crossref","unstructured":"Nicolas P (2009) Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides. FEBS J","DOI":"10.1111\/j.1742-4658.2009.07359.x"},{"key":"10533_CR36","doi-asserted-by":"publisher","first-page":"8245","DOI":"10.1073\/pnas.150518097","volume":"97","author":"CB Park","year":"2000","unstructured":"Park CB, Yi KS, Matsuzaki K et al (2000) Structure-activity analysis of Buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of Buforin II. Proc Natl Acad Sci U S A 97:8245\u20138250. https:\/\/doi.org\/10.1073\/pnas.150518097","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10533_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","volume":"244","author":"CB Park","year":"1998","unstructured":"Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide Buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253\u2013257. https:\/\/doi.org\/10.1006\/bbrc.1998.8159","journal-title":"Biochem Biophys Res Commun"},{"key":"10533_CR38","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1016\/s0021-9258(18)42830-x","volume":"267","author":"ME Selsted","year":"1992","unstructured":"Selsted ME, Novotny MJ, Morris WL et al (1992) Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 267:4292\u20134295. https:\/\/doi.org\/10.1016\/s0021-9258(18)42830-x","journal-title":"J Biol Chem"},{"key":"10533_CR39","doi-asserted-by":"publisher","first-page":"19298","DOI":"10.1074\/jbc.271.32.19298","volume":"271","author":"TJ Falla","year":"1996","unstructured":"Falla TJ, Nedra Karunaratne D, Hancock REW (1996) Mode of action of the antimicrobial peptide Indolicidin. J Biol Chem 271:19298\u201319303. https:\/\/doi.org\/10.1074\/jbc.271.32.19298","journal-title":"J Biol Chem"},{"key":"10533_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0014-5793(96)00996-9","volume":"395","author":"C Subbalakshmi","year":"1996","unstructured":"Subbalakshmi C, Krishnakumari V, Nagaraj R, Sitaram N (1996) Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide Indolicidin. FEBS Lett 395:48\u201352. https:\/\/doi.org\/10.1016\/0014-5793(96)00996-9","journal-title":"FEBS Lett"},{"key":"10533_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0378-1097(98)00008-1","volume":"160","author":"C Subbalakshmi","year":"1998","unstructured":"Subbalakshmi C, Sitaram N (1998) Mechanism of antimicrobial action of Indolicidin. FEMS Microbiol Lett 160:91\u201396. https:\/\/doi.org\/10.1016\/S0378-1097(98)00008-1","journal-title":"FEMS Microbiol Lett"},{"key":"10533_CR42","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1093\/nar\/gki725","volume":"33","author":"CH Hsu","year":"2005","unstructured":"Hsu CH, Chen C, Jou ML et al (2005) Structural and DNA-binding studies on the bovine antimicrobial peptide, Indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res 33:4053\u20134064. https:\/\/doi.org\/10.1093\/nar\/gki725","journal-title":"Nucleic Acids Res"},{"key":"10533_CR43","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/cmdc.201402215","volume":"9","author":"A Ghosh","year":"2014","unstructured":"Ghosh A, Kar RK, Jana J et al (2014) Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy. ChemMedChem 9:2052\u20132058. https:\/\/doi.org\/10.1002\/cmdc.201402215","journal-title":"ChemMedChem"},{"key":"10533_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2004.05.017","volume":"14","author":"K Adelman","year":"2004","unstructured":"Adelman K, Yuzenkova J, La Porta A et al (2004) Molecular mechanism of transcription Inhibition by peptide antibiotic microcin J25. Mol Cell 14:753\u2013762. https:\/\/doi.org\/10.1016\/j.molcel.2004.05.017","journal-title":"Mol Cell"},{"key":"10533_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/mcp.M111.014720","volume":"11","author":"YH Ho","year":"2012","unstructured":"Ho YH, Sung TC, Chen CS (2012) Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB. Mol Cell Proteom 11:1\u201310. https:\/\/doi.org\/10.1074\/mcp.M111.014720","journal-title":"Mol Cell Proteom"},{"key":"10533_CR46","doi-asserted-by":"publisher","unstructured":"Tu YH, Ho YH, Chuang YC et al (2011) Identification of lactoferricin B intracellular targets using an escherichia coli proteome chip. PLoS ONE 6. https:\/\/doi.org\/10.1371\/journal.pone.0028197","DOI":"10.1371\/journal.pone.0028197"},{"key":"10533_CR47","doi-asserted-by":"crossref","unstructured":"Schnapp D, Kemp GD, Smith VJ (1996) Purification and characterization of a proline-rich antibacterial peptide, with Sequence Similarity to Bactenecin-7, from the Haemocytes of the Shore Crab, Carcinus Maenas. Eur J Biochem. 539:532\u2013539","DOI":"10.1111\/j.1432-1033.1996.0532h.x"},{"key":"10533_CR48","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.chembiol.2014.10.009","volume":"21","author":"M Mardirossian","year":"2014","unstructured":"Mardirossian M, Grzela R, Giglione C et al (2014) The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem Biol 21:1639\u20131647. https:\/\/doi.org\/10.1016\/j.chembiol.2014.10.009","journal-title":"Chem Biol"},{"key":"10533_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep09761","volume":"5","author":"CF Le","year":"2015","unstructured":"Le CF, Yusof MYM, Hassan H, Sekaran SD (2015) In vitro properties of designed antimicrobial peptides that exhibit potent Antipneumococcal activity and produces synergism in combination with penicillin. Sci Rep 5:1\u20138. https:\/\/doi.org\/10.1038\/srep09761","journal-title":"Sci Rep"},{"key":"10533_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26828","volume":"6","author":"CF Le","year":"2016","unstructured":"Le CF, Gudimella R, Razali R et al (2016) Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3. Sci Rep 6:1\u20139. https:\/\/doi.org\/10.1038\/srep26828","journal-title":"Sci Rep"},{"key":"10533_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri.2016.29","volume":"16","author":"REW Hancock","year":"2016","unstructured":"Hancock REW, Haney EF, Gill EE (2016) The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol 16:321\u2013334","journal-title":"Nat Rev Immunol"},{"key":"10533_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1119574","volume":"14","author":"DI Duarte-Mata","year":"2023","unstructured":"Duarte-Mata DI, Salinas-Carmona MC (2023) Antimicrobial peptides\u00b4 immune modulation role in intracellular bacterial infection. Front Immunol 14:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2023.1119574","journal-title":"Front Immunol"},{"key":"10533_CR53","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1042\/BST20060276","volume":"34","author":"PS Hiemstra","year":"2006","unstructured":"Hiemstra PS (2006) Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem Soc Trans 34:276\u2013278. https:\/\/doi.org\/10.1042\/BST20060276","journal-title":"Biochem Soc Trans"},{"key":"10533_CR54","doi-asserted-by":"crossref","unstructured":"Tan BH, Meinken C, Bastian M et al (2006) Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens. J Immunol","DOI":"10.4049\/jimmunol.177.3.1864"},{"key":"10533_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08196.x","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Niyonsaba F, Ushio H et al (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human \u03b1-defensins from neutrophils. Br J Dermatol. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08196.x","journal-title":"Br J Dermatol"},{"key":"10533_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cytogfr.2014.12.005","volume":"26","author":"M Suarez-Carmona","year":"2015","unstructured":"Suarez-Carmona M, Hubert P, Delvenne P, Herfs M (2015) Defensins: simple antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev 26:361\u2013370. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.12.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10533_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1189\/jlb.68.1.9","volume":"68","author":"D Yang","year":"2000","unstructured":"Yang D, Chen Q, Chertov O, Oppenheim JJ (2000) Human neutrophil defensins selectively chemoattract Naive T and immature dendritic cells. J Leukoc Biol 68:9\u201314. https:\/\/doi.org\/10.1189\/jlb.68.1.9","journal-title":"J Leukoc Biol"},{"key":"10533_CR58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s004410100433","volume":"306","author":"JRC Garc\u00eda","year":"2001","unstructured":"Garc\u00eda JRC, Jaumann F, Schulz S et al (2001) Identification of a novel, multifunctional \u03b2-defensin (human \u03b2-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306:257\u2013264. https:\/\/doi.org\/10.1007\/s004410100433","journal-title":"Cell Tissue Res"},{"key":"10533_CR59","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.4049\/jimmunol.0903984","volume":"184","author":"J R\u00f6hrl","year":"2010","unstructured":"R\u00f6hrl J, Yang D, Oppenheim JJ, Hehlgans T (2010) Human \u03b2-Defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184:6688\u20136694. https:\/\/doi.org\/10.4049\/jimmunol.0903984","journal-title":"J Immunol"},{"key":"10533_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2019.00001","volume":"7","author":"HK Lim","year":"2019","unstructured":"Lim HK, O\u2019Neill HC (2019) Identification of stromal cells in spleen which support myelopoiesis. Front Cell Dev Biol 7:1\u201313. https:\/\/doi.org\/10.3389\/fcell.2019.00001","journal-title":"Front Cell Dev Biol"},{"key":"10533_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jss.2007.12.754","volume":"149","author":"J Engelmayer","year":"2008","unstructured":"Engelmayer J, Blezinger P, Varadhachary A (2008) Talactoferrin stimulates wound healing with modulation of inflammation. J Surg Res 149:278\u2013286. https:\/\/doi.org\/10.1016\/j.jss.2007.12.754","journal-title":"J Surg Res"},{"key":"10533_CR62","doi-asserted-by":"publisher","unstructured":"Gaio V, Cerca N (2019) Cells released from S. epidermidis biofilms present increased antibiotic tolerance to multiple antibiotics. https:\/\/doi.org\/10.7717\/peerj.6884. PeerJ 2019:","DOI":"10.7717\/peerj.6884"},{"key":"10533_CR63","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/pathogens3030743","volume":"3","author":"C Vuotto","year":"2014","unstructured":"Vuotto C, Longo F, Balice MP et al (2014) Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 3:743\u2013758. https:\/\/doi.org\/10.3390\/pathogens3030743","journal-title":"Pathogens"},{"key":"10533_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/NSA.S325594","volume":"14","author":"S Amankwah","year":"2021","unstructured":"Amankwah S, Abdella K, Kassa T (2021) Bacterial biofilm destruction: A focused review on the recent use of phage-based strategies with other antibiofilm agents. Nanotechnol Sci Appl 14:161\u2013177. https:\/\/doi.org\/10.2147\/NSA.S325594","journal-title":"Nanotechnol Sci Appl"},{"key":"10533_CR65","doi-asserted-by":"publisher","unstructured":"Shariati A, Arshadi M, Khosrojerdi MA et al (2022) The resistance mechanisms of bacteria against Ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Heal 10. https:\/\/doi.org\/10.3389\/fpubh.2022.1025633","DOI":"10.3389\/fpubh.2022.1025633"},{"key":"10533_CR66","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.1128\/AEM.02636-13","volume":"79","author":"TK Wood","year":"2013","unstructured":"Wood TK, Knabel SJ, Kwan BW (2013) Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79:7116\u20137121. https:\/\/doi.org\/10.1128\/AEM.02636-13","journal-title":"Appl Environ Microbiol"},{"key":"10533_CR67","doi-asserted-by":"publisher","first-page":"e01067","DOI":"10.1016\/j.heliyon.2018.e01067","volume":"4","author":"Z Khatoon","year":"2018","unstructured":"Khatoon Z, McTiernan CD, Suuronen EJ et al (2018) Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon 4:e01067. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e01067","journal-title":"Heliyon"},{"key":"10533_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jmii.2016.12.005","volume":"50","author":"PY Chung","year":"2017","unstructured":"Chung PY, Khanum R (2017) Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect 50:405\u2013410. https:\/\/doi.org\/10.1016\/j.jmii.2016.12.005","journal-title":"J Microbiol Immunol Infect"},{"key":"10533_CR69","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2180-11-114","volume":"11","author":"SN Dean","year":"2011","unstructured":"Dean SN, Bishop BM, van Hoek ML (2011) Natural and synthetic Cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 11:114. https:\/\/doi.org\/10.1186\/1471-2180-11-114","journal-title":"BMC Microbiol"},{"key":"10533_CR70","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/IAI.00318-08","volume":"76","author":"J Overhage","year":"2008","unstructured":"Overhage J, Campisano A, Bains M et al (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176\u20134182. https:\/\/doi.org\/10.1128\/IAI.00318-08","journal-title":"Infect Immun"},{"key":"10533_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1472-765X.2009.02778.x","volume":"50","author":"\u00c9 Hell","year":"2010","unstructured":"Hell \u00c9, Giske CG, Nelson A et al (2010) Human Cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 50:211\u2013215. https:\/\/doi.org\/10.1111\/j.1472-765X.2009.02778.x","journal-title":"Lett Appl Microbiol"},{"key":"10533_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/08927010903216572","volume":"26","author":"M Yoshinari","year":"2010","unstructured":"Yoshinari M, Kato T, Matsuzaka K et al (2010) Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides. Biofouling 26:103\u2013110. https:\/\/doi.org\/10.1080\/08927010903216572","journal-title":"Biofouling"},{"key":"10533_CR73","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1128\/AAC.02473-13","volume":"58","author":"R Gopal","year":"2014","unstructured":"Gopal R, Kim YG, Lee JH et al (2014) Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant acinetobacter baumannii strains. Antimicrob Agents Chemother 58:1622\u20131629. https:\/\/doi.org\/10.1128\/AAC.02473-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR74","doi-asserted-by":"publisher","unstructured":"Yasir M, Willcox MDP, Dutta D (2018) Action of antimicrobial peptides against bacterial biofilms. Mater (Basel) 11. https:\/\/doi.org\/10.3390\/ma11122468","DOI":"10.3390\/ma11122468"},{"key":"10533_CR75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jgar.2020.02.001","volume":"22","author":"S Mermer","year":"2020","unstructured":"Mermer S, Turhan T, Bolat E et al (2020) Ceftaroline versus Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model. J Glob Antimicrob Resist 22:147\u2013151. https:\/\/doi.org\/10.1016\/j.jgar.2020.02.001","journal-title":"J Glob Antimicrob Resist"},{"key":"10533_CR76","doi-asserted-by":"publisher","first-page":"e22376","DOI":"10.1097\/md.0000000000022376","volume":"99","author":"Y Peng","year":"2020","unstructured":"Peng Y, Li C, Yang Z, Shi W (2020) Adverse reactions of Vancomycin in humans. Med (Baltim) 99:e22376. https:\/\/doi.org\/10.1097\/md.0000000000022376","journal-title":"Med (Baltim)"},{"key":"10533_CR77","doi-asserted-by":"publisher","unstructured":"Benoit L, Gray MH, Sligl WI (2012) Severe tremor due to Vancomycin therapy: A case report and literature review. Int J Infect Dis 16. https:\/\/doi.org\/10.1016\/j.ijid.2012.03.013","DOI":"10.1016\/j.ijid.2012.03.013"},{"key":"10533_CR78","doi-asserted-by":"publisher","unstructured":"Khakurel S, Rawal S (2021) Vancomycin induced cardiac arrest: a case report. J Med Case Rep 15. https:\/\/doi.org\/10.1186\/s13256-020-02639-8","DOI":"10.1186\/s13256-020-02639-8"},{"key":"10533_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/154703a0","volume":"154","author":"GF Gause","year":"1944","unstructured":"Gause GF, Brazhnikova MG (1944) Gramicidin S and its use in the treatment of infected wounds [3]. Nature 154:703","journal-title":"Nature"},{"key":"10533_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0031-6997(25)07330-2","volume":"5","author":"UMBREIT WW","year":"1953","unstructured":"UMBREIT WW (1953) Mechanisms of antibacterial action. Pharmacol Rev 5:275\u2013284","journal-title":"Pharmacol Rev"},{"key":"10533_CR81","unstructured":"Nguyen R, Sun Y (2019) Bacitracin Topical"},{"key":"10533_CR82","doi-asserted-by":"publisher","first-page":"919","DOI":"10.18006\/2023.11(6).919.929","volume":"11","author":"S Sahoo","year":"2023","unstructured":"Sahoo S, Mohanty JN, Routray SP et al (2023) Colistin the last resort drug in 21st century antibiotics to combat multidrug resistance superbugs. J Exp Biol Agric Sci 11:919\u2013929","journal-title":"J Exp Biol Agric Sci"},{"key":"10533_CR83","doi-asserted-by":"publisher","unstructured":"Kilic I, Ayar Y, Ceylan \u0130 et al (2023) Nephrotoxicity caused by colistin use in ICU: a single centre experience. BMC Nephrol 24. https:\/\/doi.org\/10.1186\/s12882-023-03334-8","DOI":"10.1186\/s12882-023-03334-8"},{"key":"10533_CR84","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12879-024-09759-2","volume":"24","author":"AF AYSERT-YILDIZ P, \u00d6ZGEN-TOP \u00d6, \u015eENT\u00dc","year":"2024","unstructured":"AYSERT-YILDIZ P, \u00d6ZGEN-TOP \u00d6, \u015eENT\u00dcRK AF et al (2024) Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins. BMC Infect Dis 24:862. https:\/\/doi.org\/10.1186\/s12879-024-09759-2","journal-title":"BMC Infect Dis"},{"key":"10533_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8609218","author":"Y Ye","year":"2019","unstructured":"Ye Y, Xia Z, Zhang D et al (2019) Multifunctional pharmaceutical effects of the antibiotic daptomycin. Biomed Res Int 2019. https:\/\/doi.org\/10.1155\/2019\/8609218","journal-title":"Biomed Res Int 2019"},{"key":"10533_CR86","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00006-08","volume":"21","author":"D Landman","year":"2008","unstructured":"Landman D, Georgescu C, Martin DA, Quale J (2008) Polymyxins revisited. Clin Microbiol Rev 21:449\u2013465. https:\/\/doi.org\/10.1128\/CMR.00006-08","journal-title":"Clin Microbiol Rev"},{"key":"10533_CR87","doi-asserted-by":"publisher","unstructured":"Xuan J, Feng W, Wang J et al (2023) Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat 68, 100954. https:\/\/doi.org\/10.1016\/j.drup.2023.100954","DOI":"10.1016\/j.drup.2023.100954"},{"key":"10533_CR88","doi-asserted-by":"crossref","unstructured":"Baindara P, Mandal SM (2023) Gut-Antimicrobial Peptides: Synergistic Co-Evolution with Antibiotics to Combat Multi-Antibiotic Resistance. Antibiotics 12","DOI":"10.3390\/antibiotics12121732"},{"key":"10533_CR89","doi-asserted-by":"crossref","unstructured":"Baindara P, Dinata R, Mandal SM (2024) Marine Bacteriocins: An Evolutionary Gold Mine to Payoff Antibiotic Resistance. Mar. Drugs 22","DOI":"10.20944\/preprints202408.0442.v1"},{"key":"10533_CR90","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1086\/424463","volume":"190","author":"A Kalita","year":"2004","unstructured":"Kalita A, Verma I, Khuller GK (2004) Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J Infect Dis 190:1476\u20131480. https:\/\/doi.org\/10.1086\/424463","journal-title":"J Infect Dis"},{"key":"10533_CR91","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000316","author":"P Baindara","year":"2016","unstructured":"Baindara P, Singh N, Ranjan M et al (2016) Laterosporulin10: A novel defensin like class Iid bacteriocin from brevibacillus Sp. strain SKDU10 with inhibitory activity against microbial pathogens. Microbiol (United Kingdom). https:\/\/doi.org\/10.1099\/mic.0.000316","journal-title":"Microbiol (United Kingdom)"},{"key":"10533_CR92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.resmic.2011.11.002","volume":"163","author":"K Naghmouchi","year":"2012","unstructured":"Naghmouchi K, Le Lay C, Baah J, Drider D (2012) Antibiotic and antimicrobial peptide combinations: synergistic Inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101\u2013108. https:\/\/doi.org\/10.1016\/j.resmic.2011.11.002","journal-title":"Res Microbiol"},{"key":"10533_CR93","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dkf190","volume":"50","author":"W Brumfitt","year":"2002","unstructured":"Brumfitt W, Salton MRJ, Hamilton-Miller JMT (2002) Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother 50:731\u2013734. https:\/\/doi.org\/10.1093\/jac\/dkf190","journal-title":"J Antimicrob Chemother"},{"key":"10533_CR94","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/jac\/44.5.641","volume":"44","author":"A Giacometti","year":"1999","unstructured":"Giacometti A, Cirioni O, Barchiesi F et al (1999) In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J Antimicrob Chemother 44:641\u2013645. https:\/\/doi.org\/10.1093\/jac\/44.5.641","journal-title":"J Antimicrob Chemother"},{"key":"10533_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.peptides.2013.09.014","volume":"50","author":"G Lebel","year":"2013","unstructured":"Lebel G, Pich\u00e9 F, Frenette M et al (2013) Antimicrobial activity of Nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics. Peptides 50:19\u201323. https:\/\/doi.org\/10.1016\/j.peptides.2013.09.014","journal-title":"Peptides"},{"key":"10533_CR96","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1128\/AAC.01180-12","volume":"56","author":"E Mataraci","year":"2012","unstructured":"Mataraci E, Dosler S (2012) In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother 56:6366\u20136371. https:\/\/doi.org\/10.1128\/AAC.01180-12","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR97","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/c5md00373c","volume":"7","author":"MG De Gier","year":"2016","unstructured":"De Gier MG, Bauke Albada H, Josten M et al (2016) Synergistic activity of a short lipidated antimicrobial peptide (lipoAMP) and colistin or tobramycin against Pseudomonas aeruginosa from cystic fibrosis patients. Medchemcomm 7:148\u2013156. https:\/\/doi.org\/10.1039\/c5md00373c","journal-title":"Medchemcomm"},{"key":"10533_CR98","doi-asserted-by":"publisher","unstructured":"Duong L, Gross SP, Siryaporn A (2021) Developing antimicrobial synergy with AMPs. Front Med Technol 3. https:\/\/doi.org\/10.3389\/fmedt.2021.640981","DOI":"10.3389\/fmedt.2021.640981"},{"key":"10533_CR99","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1389203053027494","volume":"6","author":"D Bowdish","year":"2005","unstructured":"Bowdish D, Davidson D, Hancock R (2005) A Re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6:35\u201351. https:\/\/doi.org\/10.2174\/1389203053027494","journal-title":"Curr Protein Pept Sci"},{"key":"10533_CR100","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/383472","volume":"38","author":"CF Carpenter","year":"2004","unstructured":"Carpenter CF, Chambers HF (2004) Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 38:994\u20131000","journal-title":"Clin Infect Dis"},{"key":"10533_CR101","doi-asserted-by":"crossref","unstructured":"Dubashynskaya NV, Skorik YA (2020) Polymyxin delivery systems: recent advances and challenges. Pharmaceuticals 13","DOI":"10.3390\/ph13050083"},{"key":"10533_CR102","doi-asserted-by":"publisher","unstructured":"Berditsch M, Afonin S, Reuster J et al (2019) Supreme activity of Gramicidin S against resistant, persistent and biofilm cells of Staphylococci and enterococci. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-54212-z","DOI":"10.1038\/s41598-019-54212-z"},{"key":"10533_CR103","doi-asserted-by":"crossref","unstructured":"Sharma J, Sharma D, Singh A, Sunita K (2022) Colistin Resistance and Management of Drug Resistant Infections. Can. J. Infect. Dis. Med. Microbiol. 2022","DOI":"10.1155\/2022\/4315030"},{"key":"10533_CR104","doi-asserted-by":"publisher","first-page":"832","DOI":"10.7164\/antibiotics.45.832","volume":"45","author":"S Chatterjee","year":"1992","unstructured":"Chatterjee S, Chatterjee S, Lad SJ et al (1992) Mersacidin, a new antibiotic from bacillus fermentation, isolation, purification and chemical characterization. J Antibiot (Tokyo) 45:832\u2013838. https:\/\/doi.org\/10.7164\/antibiotics.45.832","journal-title":"J Antibiot (Tokyo)"},{"key":"10533_CR105","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.febslet.2005.01.083","volume":"579","author":"MB Ekkelenkamp","year":"2005","unstructured":"Ekkelenkamp MB, Hanssen M, Hsu STD et al (2005) Isolation and structural characterization of Epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett 579:1917\u20131922. https:\/\/doi.org\/10.1016\/j.febslet.2005.01.083","journal-title":"FEBS Lett"},{"key":"10533_CR106","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0014-5793(97)00425-0","volume":"410","author":"M Mota-Meira","year":"1997","unstructured":"Mota-Meira M, Lacroix C, Lapointe G, Lavoie MC (1997) Purification and structure of mutacin B-Ny266: A new lantibiotic produced by Streptococcus mutans. FEBS Lett 410:275\u2013279. https:\/\/doi.org\/10.1016\/S0014-5793(97)00425-0","journal-title":"FEBS Lett"},{"key":"10533_CR107","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dkw457","volume":"72","author":"S Halliwell","year":"2017","unstructured":"Halliwell S, Warn P, Sattar A et al (2017) A single dose of epidermicin NI01 is sufficient to eradicate MRSA from the Nares of cotton rats. J Antimicrob Chemother 72:778\u2013781. https:\/\/doi.org\/10.1093\/jac\/dkw457","journal-title":"J Antimicrob Chemother"},{"key":"10533_CR108","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00253-012-4041-0","volume":"95","author":"S Boakes","year":"2012","unstructured":"Boakes S, Ayala T, Herman M et al (2012) Generation of an actagardine A variant library through saturation mutagenesis. Appl Microbiol Biotechnol 95:1509\u20131517. https:\/\/doi.org\/10.1007\/s00253-012-4041-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"10533_CR109","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0022-2836(02)00368-6","volume":"319","author":"DJA Netz","year":"2002","unstructured":"Netz DJA, Pohl R, Beck-Sickinger AG et al (2002) Biochemical characterisation and genetic analysis of Aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol 319:745\u2013756. https:\/\/doi.org\/10.1016\/S0022-2836(02)00368-6","journal-title":"J Mol Biol"},{"key":"10533_CR110","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bbrc.2019.09.013","volume":"519","author":"K Saikia","year":"2019","unstructured":"Saikia K, Belwal VK, Datta D, Chaudhary N (2019) Aromatic-rich C-terminal region of LCI is a potent antimicrobial peptide in itself. Biochem Biophys Res Commun 519:372\u2013377. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.013","journal-title":"Biochem Biophys Res Commun"},{"key":"10533_CR111","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1128\/AAC.00744-09","volume":"54","author":"G Vassiliadis","year":"2010","unstructured":"Vassiliadis G, Destoumieux-Garz\u00f3n D, Lombard C et al (2010) Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother 54:288\u2013297. https:\/\/doi.org\/10.1128\/AAC.00744-09","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR112","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish E, Sit CS, Cao S et al (2014) Lassomycin, a ribosomally synthesized Cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem Biol 21:509\u2013518. https:\/\/doi.org\/10.1016\/j.chembiol.2014.01.014","journal-title":"Chem Biol"},{"key":"10533_CR113","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijpddr.2018.03.002","volume":"8","author":"M Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M, Bart JM, Campos-Salinas J et al (2018) Autophagic-related cell death of trypanosoma brucei induced by bacteriocin AS-48. Int J Parasitol Drugs Drug Resist 8:203\u2013212. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.03.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10533_CR114","doi-asserted-by":"publisher","first-page":"14512","DOI":"10.1074\/jbc.RA119.009416","volume":"294","author":"C Balty","year":"2019","unstructured":"Balty C, Guillot A, Fradale L et al (2019) Ruminococcin C, an anti-clostridial sactipeptide produced by a prominent member of the human microbiota Ruminococcus gnavus. J Biol Chem 294:14512\u201314525. https:\/\/doi.org\/10.1074\/jbc.RA119.009416","journal-title":"J Biol Chem"},{"key":"10533_CR115","doi-asserted-by":"publisher","unstructured":"Zhu S, Gao B, Umetsu Y et al (2022) Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential. EMBO Mol Med 14. https:\/\/doi.org\/10.15252\/emmm.202114499","DOI":"10.15252\/emmm.202114499"},{"key":"10533_CR116","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.peptides.2018.08.003","volume":"107","author":"B Shen","year":"2018","unstructured":"Shen B, Song J, Zhao Y et al (2018) Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity. Peptides 107:61\u201367. https:\/\/doi.org\/10.1016\/j.peptides.2018.08.003","journal-title":"Peptides"},{"key":"10533_CR117","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acschembio.3c00577","volume":"19","author":"ZJ Zhang","year":"2024","unstructured":"Zhang ZJ, Wu C, Moreira R et al (2024) Activity of gut-Derived Nisin-like lantibiotics against human gut pathogens and commensals. ACS Chem Biol 19:357\u2013369. https:\/\/doi.org\/10.1021\/acschembio.3c00577","journal-title":"ACS Chem Biol"},{"key":"10533_CR118","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01813-15","author":"P Baindara","year":"2016","unstructured":"Baindara P, Chaudhry V, Mittal G et al (2016) Characterization of the antimicrobial peptide Penisin, a class Ia novel lantibiotic from Paenibacillus Sp. strain A3. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01813-15","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR119","doi-asserted-by":"publisher","unstructured":"Baindara P, Roy D, Mandal SM (2024) CycP: A novel Self-Assembled Vesicle-Forming Cyclic antimicrobial peptide to control Drug-Resistant S. aureus. Bioengineering 11, 855. https:\/\/doi.org\/10.3390\/bioengineering11080855","DOI":"10.3390\/bioengineering11080855"},{"key":"10533_CR120","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature04051","volume":"437","author":"PH Mygind","year":"2005","unstructured":"Mygind PH, Fischer RL, Schnorr KM et al (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975\u2013980. https:\/\/doi.org\/10.1038\/nature04051","journal-title":"Nature"},{"key":"10533_CR121","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1073\/pnas.1201263109","volume":"109","author":"S Zhu","year":"2012","unstructured":"Zhu S, Gao B, Harvey PJ, Craik DJ (2012) Dermatophytic defensin with antiinfective potential. Proc Natl Acad Sci U S A 109:8495\u20138500. https:\/\/doi.org\/10.1073\/pnas.1201263109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10533_CR122","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12602-012-9095-x","volume":"4","author":"C Iancu","year":"2012","unstructured":"Iancu C, Grainger A, Field D et al (2012) Comparison of the potency of the lipid II targeting antimicrobials Nisin, lacticin 3147 and Vancomycin against Gram-Positive Bacteria. Probiotics Antimicrob Proteins 4:108\u2013115. https:\/\/doi.org\/10.1007\/s12602-012-9095-x","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10533_CR123","doi-asserted-by":"publisher","unstructured":"Phelan RW, Barret M, Cotter PD et al (2013) Subtilomycin: A new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans. 1878\u20131898. https:\/\/doi.org\/10.3390\/md11061878","DOI":"10.3390\/md11061878"},{"key":"10533_CR124","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1432-1033.1988.tb14344.x-i2","volume":"177","author":"R KELLNER","year":"1988","unstructured":"KELLNER R, JUNG G, H\u00d6RNER T et al (1988) Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem 177:53\u201359. https:\/\/doi.org\/10.1111\/j.1432-1033.1988.tb14344.x-i2","journal-title":"Eur J Biochem"},{"key":"10533_CR125","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.3892\/mmr.2015.4275","volume":"12","author":"JH Choi","year":"2015","unstructured":"Choi JH, Jang AY, Lin S et al (2015) Melittin, a honeybee venom-derived antimicrobial peptide, May target methicillin-resistant Staphylococcus aureus. Mol Med Rep 12:6483\u20136490. https:\/\/doi.org\/10.3892\/mmr.2015.4275","journal-title":"Mol Med Rep"},{"key":"10533_CR126","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0965-1748(03)00028-6","volume":"33","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Johnson TJ, Myers AA, Kanost MR (2003) Identification by subtractive suppression hybridization of bacteria-induced genes expressed in Manduca sexta fat body. Insect Biochem Mol Biol 33:541\u2013559. https:\/\/doi.org\/10.1016\/S0965-1748(03)00028-6","journal-title":"Insect Biochem Mol Biol"},{"key":"10533_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics10010036","volume":"10","author":"J Peng","year":"2021","unstructured":"Peng J, Mishra B, Khader R et al (2021) Novel cecropin-4 derived peptides againstmethicillin-resistant Staphylococcus aureus. Antibiotics 10:1\u201319. https:\/\/doi.org\/10.3390\/antibiotics10010036","journal-title":"Antibiotics"},{"key":"10533_CR128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/oxfordjournals.jbchem.a123191","volume":"108","author":"T Muta","year":"1990","unstructured":"Muta T, Fujimoto T, Nakajima H, Iwanaga S (1990) Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new Tachyplesin, Tachyplesin Iii, and a processing intermediate of its precursor. J Biochem 108:261\u2013266. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a123191","journal-title":"J Biochem"},{"key":"10533_CR129","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.febslet.2004.10.012","volume":"577","author":"TV Ovchinnikova","year":"2004","unstructured":"Ovchinnikova TV, Aleshina GM, Balandin SV et al (2004) Purification and primary structure of two isoforms of Arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina. FEBS Lett 577:209\u2013214. https:\/\/doi.org\/10.1016\/j.febslet.2004.10.012","journal-title":"FEBS Lett"},{"key":"10533_CR130","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","volume":"84","author":"M Zasloff","year":"1987","unstructured":"Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84:5449\u20135453. https:\/\/doi.org\/10.1073\/pnas.84.15.5449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10533_CR131","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1016\/s0021-9258(17)34136-4","volume":"269","author":"DP Clark","year":"1994","unstructured":"Clark DP, Durell S, Maloy WL, Zasloff M (1994) Ranalexin: A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J Biol Chem 269:10849\u201310855. https:\/\/doi.org\/10.1016\/s0021-9258(17)34136-4","journal-title":"J Biol Chem"},{"key":"10533_CR132","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.bbapap.2010.01.015","volume":"1804","author":"AP Subasinghage","year":"2010","unstructured":"Subasinghage AP, Conlon JM, Hewage CM (2010) Development of potent anti-infective agents from Silurana tropicalis: conformational analysis of the amphipathic, alpha-helical antimicrobial peptide XT-7 and its non-haemolytic analogue [G4K]XT-7. Biochim Biophys Acta - Proteins Proteom 1804:1020\u20131028. https:\/\/doi.org\/10.1016\/j.bbapap.2010.01.015","journal-title":"Biochim Biophys Acta - Proteins Proteom"},{"key":"10533_CR133","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cbpc.2005.11.022","volume":"143","author":"JM Conlon","year":"2006","unstructured":"Conlon JM, Al-Ghaferi N, Abraham B et al (2006) Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Comp Biochem Physiol - C Toxicol Pharmacol 143:42\u201349. https:\/\/doi.org\/10.1016\/j.cbpc.2005.11.022","journal-title":"Comp Biochem Physiol - C Toxicol Pharmacol"},{"key":"10533_CR134","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.toxicon.2007.06.023","volume":"50","author":"JM Conlon","year":"2007","unstructured":"Conlon JM, Kolodziejek J, Nowotny N et al (2007) Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii. Toxicon 50:746\u2013756. https:\/\/doi.org\/10.1016\/j.toxicon.2007.06.023","journal-title":"Toxicon"},{"key":"10533_CR135","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.peptides.2018.05.011","volume":"106","author":"B Mishra","year":"2018","unstructured":"Mishra B, Wang X, Lushnikova T et al (2018) Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins. Peptides 106:9\u201320. https:\/\/doi.org\/10.1016\/j.peptides.2018.05.011","journal-title":"Peptides"},{"key":"10533_CR136","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.regpep.2005.06.003","volume":"131","author":"JM Conlon","year":"2005","unstructured":"Conlon JM, Abraham B, Sonnevend A et al (2005) Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Regul Pept 131:38\u201345. https:\/\/doi.org\/10.1016\/j.regpep.2005.06.003","journal-title":"Regul Pept"},{"key":"10533_CR137","doi-asserted-by":"publisher","first-page":"16880","DOI":"10.1074\/jbc.M109.097204","volume":"285","author":"F Abbassi","year":"2010","unstructured":"Abbassi F, Lequin O, Piesse C et al (2010) Temporin-SHf, a new type of Phe-rich and hydrophobic ultrashort antimicrobial peptide. J Biol Chem 285:16880\u201316892. https:\/\/doi.org\/10.1074\/jbc.M109.097204","journal-title":"J Biol Chem"},{"key":"10533_CR138","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.peptides.2012.07.005","volume":"37","author":"JM Conlon","year":"2012","unstructured":"Conlon JM, Mechkarska M, Prajeep M et al (2012) Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Peptides 37:113\u2013119. https:\/\/doi.org\/10.1016\/j.peptides.2012.07.005","journal-title":"Peptides"},{"key":"10533_CR139","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bbagen.2019.02.013","volume":"1863","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Zai Y, Xi X et al (2019) A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using galleria Mellonella model. Biochim Biophys Acta - Gen Subj 1863:849\u2013856. https:\/\/doi.org\/10.1016\/j.bbagen.2019.02.013","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"10533_CR140","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/cbic.202000816","volume":"22","author":"J Portelinha","year":"2021","unstructured":"Portelinha J, Angeles-Boza AM (2021) The antimicrobial peptide Gad-1 clears Pseudomonas aeruginosa biofilms under cystic fibrosis conditions. ChemBioChem 22:1646\u20131655. https:\/\/doi.org\/10.1002\/cbic.202000816","journal-title":"ChemBioChem"},{"key":"10533_CR141","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijantimicag.2012.02.003","volume":"39","author":"J Menousek","year":"2012","unstructured":"Menousek J, Mishra B, Hanke ML et al (2012) Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. Int J Antimicrob Agents 39:402\u2013406. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.02.003","journal-title":"Int J Antimicrob Agents"},{"key":"10533_CR142","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.peptides.2011.06.008","volume":"32","author":"R Tao","year":"2011","unstructured":"Tao R, Tong Z, Lin Y et al (2011) Antimicrobial and antibiofilm activity of pleurocidin against cariogenic microorganisms. Peptides 32:1748\u20131754. https:\/\/doi.org\/10.1016\/j.peptides.2011.06.008","journal-title":"Peptides"},{"key":"10533_CR143","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1128\/AAC.01436-08","volume":"53","author":"Z Zhao","year":"2009","unstructured":"Zhao Z, Ma Y, Dai C et al (2009) Imcroporin, a new cationic antimicrobial peptide from the venom of the Scorpion isometrus maculates. Antimicrob Agents Chemother 53:3472\u20133477. https:\/\/doi.org\/10.1128\/AAC.01436-08","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR144","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.peptides.2015.03.003","volume":"68","author":"ET De Melo","year":"2015","unstructured":"De Melo ET, Estrela AB, Santos ECG et al (2015) Structural characterization of a novel peptide with antimicrobial activity from the venom gland of the Scorpion Tityus stigmurus: Stigmurin. Peptides 68:3\u201310. https:\/\/doi.org\/10.1016\/j.peptides.2015.03.003","journal-title":"Peptides"},{"key":"10533_CR145","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7150\/ijbs.23419","volume":"14","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang L, Wu Y et al (2018) Evaluation of the bioactivity of a mastoparan peptide from Wasp venom and of its analogues designed through targeted engineering. Int J Biol Sci 14:599\u2013607. https:\/\/doi.org\/10.7150\/ijbs.23419","journal-title":"Int J Biol Sci"},{"key":"10533_CR146","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1074\/jbc.M507180200","volume":"281","author":"Y Xiao","year":"2006","unstructured":"Xiao Y, Cai Y, Bommineni YR et al (2006) Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 281:2858\u20132867. https:\/\/doi.org\/10.1074\/jbc.M507180200","journal-title":"J Biol Chem"},{"key":"10533_CR147","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.molimm.2009.05.019","volume":"46","author":"A van Dijk","year":"2009","unstructured":"van Dijk A, Molhoek EM, Veldhuizen EJA et al (2009) Identification of chicken cathelicidin-2 core elements involved in antibacterial and Immunomodulatory activities. Mol Immunol 46:2465\u20132473. https:\/\/doi.org\/10.1016\/j.molimm.2009.05.019","journal-title":"Mol Immunol"},{"key":"10533_CR148","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1128\/iai.65.7.2898-2903.1997","volume":"65","author":"IN Hee Lee","year":"1997","unstructured":"Hee Lee IN, Cho Y, Lehrer RI (1997) Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 65:2898\u20132903. https:\/\/doi.org\/10.1128\/iai.65.7.2898-2903.1997","journal-title":"Infect Immun"},{"key":"10533_CR149","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0014-5793(99)01600-2","volume":"463","author":"B Skerlavaj","year":"1999","unstructured":"Skerlavaj B, Benincasa M, Risso A et al (1999) SMAP-29: A potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463:58\u201362. https:\/\/doi.org\/10.1016\/S0014-5793(99)01600-2","journal-title":"FEBS Lett"},{"key":"10533_CR150","doi-asserted-by":"publisher","first-page":"28375","DOI":"10.1074\/jbc.271.45.28375","volume":"271","author":"B Skerlavaj","year":"1996","unstructured":"Skerlavaj B, Gennaro R, Bagella L et al (1996) Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271:28375\u201328381. https:\/\/doi.org\/10.1074\/jbc.271.45.28375","journal-title":"J Biol Chem"},{"key":"10533_CR151","doi-asserted-by":"publisher","unstructured":"Ke T, Liang S, Huang J et al (2012) A novel PCR-based method for high throughput prokaryotic expression of antimicrobial peptide genes. BMC Biotechnol 12. https:\/\/doi.org\/10.1186\/1472-6750-12-10","DOI":"10.1186\/1472-6750-12-10"},{"key":"10533_CR152","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1128\/AAC.37.12.2534","volume":"37","author":"JW Larrick","year":"1993","unstructured":"Larrick JW, Hirata M, Shimomoura Y et al (1993) Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother 37:2534\u20132539. https:\/\/doi.org\/10.1128\/AAC.37.12.2534","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR153","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.02237-12","volume":"57","author":"AA Patil","year":"2013","unstructured":"Patil AA, Ouellette AJ, Lu W, Zhang G (2013) Rattusin, an intestinal \u03b1-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. Antimicrob Agents Chemother 57:1823\u20131831. https:\/\/doi.org\/10.1128\/AAC.02237-12","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR154","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1128\/iai.62.11.5040-5047.1994","volume":"62","author":"AJ Ouellette","year":"1994","unstructured":"Ouellette AJ, Hsieh MM, Nosek MT et al (1994) Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous Cryptdin isoforms. Infect Immun 62:5040\u20135047. https:\/\/doi.org\/10.1128\/iai.62.11.5040-5047.1994","journal-title":"Infect Immun"},{"key":"10533_CR155","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1248\/cpb.43.853","volume":"43","author":"H Tamamura","year":"1995","unstructured":"Tamamura H, Sugihara K, Otaka A et al (1995) Synthesis of Protegrin-Related peptides and their antibacterial and Anti-human immunodeficiency virus activity. Chem Pharm Bull 43:853\u2013858. https:\/\/doi.org\/10.1248\/cpb.43.853","journal-title":"Chem Pharm Bull"},{"key":"10533_CR156","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.286.5439.498","volume":"286","author":"YQ Tang","year":"1999","unstructured":"Tang YQ, Yuan J, \u00d6sapay G et al (1999) A Cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated \u03b1-defensins. Sci (80-) 286:498\u2013502. https:\/\/doi.org\/10.1126\/science.286.5439.498","journal-title":"Sci (80-)"},{"key":"10533_CR157","doi-asserted-by":"publisher","unstructured":"Ridyard KE, Overhage J (2021) The potential of human peptide ll-37 as an antimicrobial and anti-biofilm agent. Antibiotics 10. https:\/\/doi.org\/10.3390\/antibiotics10060650","DOI":"10.3390\/antibiotics10060650"},{"key":"10533_CR158","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","volume":"193","author":"A Peschel","year":"2001","unstructured":"Peschel A, Jack RW, Otto M et al (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 193:1067\u20131076. https:\/\/doi.org\/10.1084\/jem.193.9.1067","journal-title":"J Exp Med"},{"key":"10533_CR159","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008557200","author":"J Harder","year":"2001","unstructured":"Harder J, Bartels J, Christophers E, Schr\u00f6der JM (2001) Isolation and characterization of human \u03b2-Defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M008557200","journal-title":"J Biol Chem"},{"key":"10533_CR160","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","volume":"2","author":"L Lin","year":"2015","unstructured":"Lin L, Nonejuie P, Munguia J et al (2015) Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly Multidrug-Resistant Gram-Negative bacterial pathogens. EBioMedicine 2:690\u2013698. https:\/\/doi.org\/10.1016\/j.ebiom.2015.05.021","journal-title":"EBioMedicine"},{"key":"10533_CR161","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijantimicag.2010.01.016","volume":"35","author":"AP Desbois","year":"2010","unstructured":"Desbois AP, Gemmell CG, Coote PJ (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 35:559\u2013565. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.01.016","journal-title":"Int J Antimicrob Agents"},{"key":"10533_CR162","doi-asserted-by":"publisher","unstructured":"Lu Y, Tian H, Chen R et al (2022) Synergistic antimicrobial effect of antimicrobial peptides CATH-1, CATH-3, and PMAP-36 with erythromycin against bacterial pathogens. Front Microbiol 13. https:\/\/doi.org\/10.3389\/fmicb.2022.953720","DOI":"10.3389\/fmicb.2022.953720"},{"key":"10533_CR163","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2180-13-212","volume":"13","author":"La Draper","year":"2013","unstructured":"Draper La, Cotter PD, Hill C, Ross RP (2013) The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit gram negative bacteria. BMC Microbiol 13:212. https:\/\/doi.org\/10.1186\/1471-2180-13-212","journal-title":"BMC Microbiol"},{"key":"10533_CR164","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1128\/AAC.00261-13","volume":"57","author":"H Mathur","year":"2013","unstructured":"Mathur H, O\u2019Connor PM, Hill C et al (2013) Analysis of anti-clostridium difficile activity of thuricin CD, Vancomycin, metronidazole, Ramoplanin, and actagardine, both singly and in paired combinations. Antimicrob Agents Chemother 57:2882\u20132886. https:\/\/doi.org\/10.1128\/AAC.00261-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR165","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12602-014-9183-1","volume":"7","author":"VL Cavera","year":"2015","unstructured":"Cavera VL, Volski A, Chikindas ML (2015) The natural antimicrobial subtilosin A synergizes with Lauramide arginine Ethyl ester (LAE), \u03b5-Poly-l-lysine (Polylysine), clindamycin phosphate and metronidazole, against the vaginal pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins 7:164\u2013171. https:\/\/doi.org\/10.1007\/s12602-014-9183-1","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10533_CR166","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.archoralbio.2008.11.007","volume":"54","author":"O Lobos","year":"2009","unstructured":"Lobos O, Padilla A, Padilla C (2009) In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains. Arch Oral Biol 54:230\u2013234. https:\/\/doi.org\/10.1016\/j.archoralbio.2008.11.007","journal-title":"Arch Oral Biol"},{"key":"10533_CR167","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/AAC.00273-11","volume":"55","author":"P Rishi","year":"2011","unstructured":"Rishi P, Preet S, Bharrhan S, Verma I (2011) In vitro and in vivo synergistic effects of Cryptdin 2 and ampicillin against Salmonella. Antimicrob Agents Chemother 55:4176\u20134182. https:\/\/doi.org\/10.1128\/AAC.00273-11","journal-title":"Antimicrob Agents Chemother"},{"key":"10533_CR168","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.resmic.2012.06.001","volume":"163","author":"H Choi","year":"2012","unstructured":"Choi H, Lee DG (2012) Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria. Res Microbiol 163:479\u2013486. https:\/\/doi.org\/10.1016\/j.resmic.2012.06.001","journal-title":"Res Microbiol"},{"key":"10533_CR169","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/jac\/dkq106","volume":"65","author":"TZ Oo","year":"2010","unstructured":"Oo TZ, Cole N, Garthwaite L et al (2010) Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection. J Antimicrob Chemother 65:1243\u20131251. https:\/\/doi.org\/10.1093\/jac\/dkq106","journal-title":"J Antimicrob Chemother"},{"key":"10533_CR170","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/AAC.02542-14","volume":"58","author":"S Nuding","year":"2014","unstructured":"Nuding S, Frasch T, Schaller M et al (2014) Synergistic effects of antimicrobial peptides and antibiotics against clostridium difficile. Antimicrob Agents Chemother 58:5719\u20135725. https:\/\/doi.org\/10.1128\/AAC.02542-14","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10533-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:26:05Z","timestamp":1766852765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10533-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10533"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10533-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}